User: Guest  Login
Title:

Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial.

Document type:
Journal Article
Author(s):
Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M; Park, J; Hochhauser, D; Arnold, D; Oh, D; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E; McGuinness, D; Cui, K; Schlienger, K; Locker, G; Kindler, H
Journal title abbreviation:
Ann Oncol
Year:
2019
Journal volume:
30 Suppl 4
Fulltext / DOI:
doi:10.1093/annonc/mdz183
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/32085054
Print-ISSN:
0923-7534
TUM Institution:
Lehrstuhl für Tumormetabolismus (Prof. Algül)
 BibTeX